OpenAlex
PricingAboutJobs
Log inGet started
Work

EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies

HTML

Year: 2026
Type: review
Source: DARU Journal of Pharmaceutical Sciences
DOI: 10.1007/s40199-026-00690-2
Authors: Suleiman Ibrahim Mohammad, Asokan Vasudevan, Tareq Nayef AlRamadneh, Ihsan K. Jasim, Tushar B. Gajjar, Malathi Hanumanthayya, Sandeep Kumar Shukla, Navin Kumar Tailor, Mirza R. Baig, Zahraa Abbas
Institutions: INTI International University, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Al-Ahliyya Amman University, Al-Turath University, Jain University, Sharda University, Chandigarh University, Islamic University of Najaf
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR, non-small cell lung cancer, EGFR mutation, tyrosine kinase inhibitors, drug resistance, T790M, C797S, exon 19 deletion, L858R, exon 20 insertion, bypass signaling, combination therapy, MEK inhibitors, MET inhibitors, AXL inhibitor, bispecific antibodies, antibody-drug conjugates, immunomodulation, nanotechnology drug delivery, liquid biopsy, circulating tumor DNA, precision oncology
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W7225639624
FWCI:
Cites: 186
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms